EUVIMEDEUVIMED entdecken
Crossref

Ceapin‐ A7 Suppresses UPR Signaling and Mitigates Retinal Neovascularization in Vldlr −/− Mice

Soyoung Park, Angela Galdamez, William Temme, Allyssa Bradley, Masako Le, Leon Chea, Ethan Stevenson, Yudith Gradilla, Eun-Jin Lee, Jonathan H Lin

The FASEB Journal · 2026

DOI: 10.1096/fj.202603175r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Soyoung Park und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Stanford University, Stanford, California, USA. Hauptthemen laut MEDLINE: Retinal Neovascularization, Receptors, LDL, Unfolded Protein Response, Signal Transduction. Die Arbeit nennt 67 Literaturangaben. Gefördert von: National Institutes of Health (NIH), VA, U.S. Department of Veterans Affairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pathological neovascularization drives blinding retinal diseases, including diabetic retinopathy, retinopathy of prematurity, and neovascular age‐related macular degeneration. Endoplasmic reticulum (ER) stress and unfolded protein response (UPR) signaling are key mechanisms underlying neovascularization. Mice lacking the UPR regulator Activating Transcription Factor 6 (ATF6) show normal retinal vasculature yet are resistant to pathologic neovascularization, suggesting that ATF6 inhibition may mitigate retinal damage and vision loss from aberrant retinal angiogenesis. We tested Ceapin‐A7, a selective ATF6 inhibitor, in Vldlr −/− mice, a genetic model of retinal neovascularization. Intravitreal Ceapin‐A7 reduced ectopic vascular projections into the outer retina and significantly increased scotopic b‐wave amplitude, while a‐wave and photopic responses showed no significant difference between groups. Single‐nucleus RNA sequencing revealed suppressed ATF6/UPR gene programs and angiogenic pathways in retinal endothelial cells and reduced Müller cell gliosis. These findings demonstrate that pharmacologic ATF6 inhibition mitigates retinal neovascularization in Vldlr −/− mice and identifies ATF6/UPR as a therapeutic target for neovascular retinal diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinal NeovascularizationReceptors, LDLUnfolded Protein ResponseSignal TransductionAnimalsMiceActivating Transcription Factor 6Mice, KnockoutMice, Inbred C57BLRetina

Stichwörter der Autor:innen

ATF6UPRVLDLRneovascularizationretinasmall molecule

Substanzen

Receptors, LDLVLDL receptorActivating Transcription Factor 6Atf6 protein, mouse

Autor:innen und Institutionen

  • Department of Pathology, Stanford University, Stanford, California, USA.
  • Department of Ophthalmology, Stanford University, Stanford, California, USA.
  • VA Palo Alto Healthcare System, Palo Alto, California, USA.

Förderung

  • National Institutes of Health (NIH)
  • VA
  • U.S. Department of Veterans Affairs

Zitieren

APA

Park, S., Galdamez, A., Temme, W., Bradley, A., Le, M., Chea, L., Stevenson, E., Gradilla, Y., Lee, E. J., & Lin, J. H. (2026). Ceapin‐ A7 Suppresses UPR Signaling and Mitigates Retinal Neovascularization in Vldlr −/− Mice. The FASEB Journal. https://doi.org/10.1096/fj.202603175r

Vancouver

Park S, Galdamez A, Temme W, Bradley A, Le M, Chea L, et al. Ceapin‐ A7 Suppresses UPR Signaling and Mitigates Retinal Neovascularization in Vldlr −/− Mice. The FASEB Journal. 2026. doi:10.1096/fj.202603175r

BibTeX
@article{Park2026,
  author = {Park, Soyoung and Galdamez, Angela and Temme, William and Bradley, Allyssa and Le, Masako and Chea, Leon and Stevenson, Ethan and Gradilla, Yudith and Lee, Eun-Jin and Lin, Jonathan H},
  title = {Ceapin‐ A7 Suppresses UPR Signaling and Mitigates Retinal Neovascularization in Vldlr −/− Mice},
  journal = {The FASEB Journal},
  year = {2026},
  doi = {10.1096/fj.202603175r}
}
Kostenlos starten →